Their Words, Not Ours
I was really impressed with the congress organization and the audience who represented top biosimilars experts worldwide. I believe the event offered an excellent platform for sharing insights and points of views of the different stake holders from both the industry and the regulators’ sides. Would certainly want to participate next year.
Dr Mourad Farouk
Medical Director @ International Development
Thank you for a good experience with the PARADIGM Global Events…
very high level, very good Organization, we overpassed our expectatives, we will be pending for another congress related to pharmaceutical and biotech… we learned a lot, and i think that the content of agenda was state of the art, thank you again.
ERP/ CRM / Product Configurator Manager
It was a pleasure presenting at this year’s conference and thank you very much for the excellent organization.
VP and Head, Biologics Research @ Janssen
Many thanks for your support at the Congress last week, I found the meeting extremely informative and the Paradigm team absolutely fantastic!
PhD, Senior Specialist, Regulatory Affairs
PGE organizes an International, high quality conference packed with highly relevant presentations by EMA biosimilar assessors, biosimilar developers and originators with a high degree of delegate interaction.
Richard Di Cicco
CEO @ Harvest Moon
Great conference, varied and very relevant material. Great speakers and organizers. Was worth attending. Looking forward to next year’s event
Dr. Hanane Cherif
Quality and Compliance Director
A very interesting conference. Comprehensive programme. Highly qualified speakers
Dr. David Uguen
Exec. Director, Voisin Consulting Life Sciences
Very useful knowledge exchange
Director @ Protagen Protein Services
Fantastic speakers, very informative event
Clinical Operations Manager @ Biovirtus Research Site
Very informative Conference.
Dr. Adrian Haines
Senior Principal senior Scientist @ Lonza Biologics
Great interactive discussion with experts in their field.
Dr. Fiona Greer
Global Director, SGS M-SCAN
The 2014 Biosimilars Global Congress stimulated collaborative discussion to facilitate advancing the science and medicine for biosimilar product access for patients
Dr. Nancy Martin
VP, Clinical Development, Hospira
The program is very informative, far more comprehensive than others of this type
Lawyer, Sughrue Mion PLLC, Litigation
The event provided a lot of different point of views about the same topic (Biosimilars)
Product Manager, Marketing, Janssen
Well moderated event, interesting presentations, comfortable location
Dr. Roberta Marcone
Analytical Development and GMP Section Manager, Patheon
Conference had topics stimulating the interest of everyone from the biosimilars novices to the experts – overall great conference
Senior Analyst, BCG
Paradigm organizes a packed high quality agenda with high quality industry and EMA assessor speakers
Chairman, Harvest Moon Pharmaceuticals USA
I was impressed with the organization of this event. I attend many conferences per year and find the organizers on site to be detached and not focus on good service to the delegates. This team was even providing weather forecast warning to ensure everyone was aware and made appropriate plans. Well Done.
Adriana E. Manzi
PhD, Managing Director, Atheln, Inc
The consistently high quality of international faculty was most impressive. It was also obvious that they were carefully chosen not only for their particular expertise but also for their ability to communicate the subject matter to clinical and non-clinical participants alike. As market access consultant for pharma clients of various sizes, I now feel much better prepared to explain the nuances & dynamics involved in bringing their products to market. In addition, I am in a much better position to intelligently advice my clients & help them set realistic expectations
Associate Vice President, VCGA - Quintiles